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from specialist diabetic clinics in London (50 subjects) and 
Sydney (30 subjects) if they were 15 to 40 years old, lifelong 
nonsmokers and nonhypertensive and had no family history of 
premature vascular disease. No subject had familial hypercho- 
lesterolemia. All subjects were clinically well, with no evidence 
of systemic or coronary artery disease and were taking no 
medication apart from insulin (or the ora! contraceptive Fill 
[combined oral contraceptive pill in IO subjects, progesterone- 
&y pill in 51). Aspirin and nonsteroidal anti-inflammatory 
drugs were avoided for 5 days before the study. 
Each subject was evaluated with a detailed history and 
physical examination (including rest supine blood pressure). 
Subjects were assessed for evidence of macrovascular (palpa- 
;)le peripheral pulses and a 12-lead ECG) and microvascular 
disease (diabetic retinopathy, peripheral neuropathy [lo] and 
proteinuria). Two or more timed urine collections were made 
to measure urinary albumin excretion rate. Autonomic func- 
tion tests ill), including heart rate and blood pressure vari- 
a!liL]: r:ith posture, Valsalva maneuver, cold pressor testing 
and mental stress testing, were performed in an unselected 
subgroup of 16 patipnts. A control group of 80 healthy, 
nonsmoking, r;cishypp.:choleslerolemic (low density lipopro- 
tein [LDL] cholesterol ~160 mg/dl), nondiabetic volunteers 
matched for ape and gender were also recruited for study from 
the hospital staff, friends and families in London. None were 
taking medication, L.icept for the oral contraceptive pill (com- 
b&d oral contraceptive pill in 12 volunteers, progesterone- 
only pill in 1). 
Of the 80 diabetic subjects, 60 were studied in the fasting 
state, and insulin was withheld before the sp-ldy. Blood samples 
wel-c: taken after a iO-h overnight fast for urea, creatinine, 
glucose, insulin and glycosyiated hemoglobin A, levels (Rapid 
EP system, Helena Laboratories). Total plasma cholesterol, 
high density lipoprotein (HDL) cholesterol (after precipitation 
of apoprotein B-containing lipoproteins) and triglyceride lev- 
els were measured (Boehringer-Mannheim GmbH diagnostic 
apparatus in London; Hitachi 747 autoanalyzer in Sydney). 
Low density lipoprotein cholesterol was calculated according 
to the Friedewald formula (12). Although total cholesterol 
levels were available for all diabetic subjects, calculated LDL 
cholesterol levels were available only in 60 fasting subjects. 
Lipoprotein(a) was measured using an enzyme-linked immu- 
nosorbent assay method (Immuno GmbH). 
All subjects gave written informed consent to the study, 
which was approved by the local ccJm&ees on ethical prac- 
tice. 
Study design. Arterial endothelium and smooth muscle 
function were studied noninvasively by examining brachial 
artery responses to endothelium-dependent and endotheliurn- 
independent stimuli, previously described (13). Arterial diam- 
eter was measured from B-mode ultipsound images at rest, in 
response to reactive hyperemia (with increased flow producing 
endothelium-dependent vasodilation), again at rest and after 
sublingual glyceryltrinitrate (GTN) (an endothelium-independent 
vasodilator), using a standard 7 MHz linear array transducer 
and Acuson 128XP/lO system. 
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The subject lay at rest >lO min before the first scau and 
rer:ained supine throughout the study. The brachial artery was 
scs-:ned in longitudinal sections 2 to 15 cm above the elbow 
an&he center of the artery identified when the clearest picture 
of .he anterior and posterior wall layers was obtained. The 
transmit (focus) zone was set to a depth of ?he near wall 
@ause of the gleater dificulty in evaluating the near- 
frompared with the far-wall “m” iine (the interface between the 
media and adventitia). Depth and gain settings were set to 
oztimize images of the lumen/arterial wall interface; images 
we:: magnified using a resolution box function (leading to a 
I$:-: width of -0.065 mm); and machine operating variables 
wzc not changed dur!;:;: the study. 
When a satisfactory transducer position was found, the skin 
ivas marked, and the arm remained ir; the sirme position 
throughout the studjr. A rest scan was then recorded. Increased 
flow was then induced by inflation of a pneumatic tourniquet 
placed around the forearm (distal to the segment of artery 
being scanned) to a pressure of 300 mm Hg for 4.5 min, 
fOllO~ti” “J lr _” C1. *-.^A h-1 =+QY= A second scan was taken 30 s before 
release of the cuff and continued for a further 90 s after cuff 
deflation. The brachial artery responses to flow using this 
technique can be blocked by infusion of NC-nitro-L-arginine 
methyl e;ter (r.-NMMA) (14), a specific antagonist for nitric 
oxide synthase, and correlated with invasive tests of coronary 
cndothelial function (15). Thereafter, 10 to 15 min was allowed 
for vessel recovery, after which a further rest scan was taken. 
Sublingual GTN spray (400 pg) was then administered and 3 to 
4 min later the last scan was performed. Doppler-derived Aow 
measurements (using a pulsed wave Doppler signal at a 70” 
angle to the vesse! with the range gate [1.5 m:n] in the center 
of the artery) were obtained during the first rest scan (baseline 
blood flow) and again during the first 15 s of reactive hyper- 
emia (allowing the flow increase to be expressed as a percent- 
age of the baseline flow). The ECG was monitored! continu- 
ously throughout the study. 
Data analysis. Ah scaus were recorded on super-VHS 
videotape for later analysis. Vessel diameters were measured 
by two independent observers (P.C., D.S.) unaware of the 
clinical details and the stage of the experiment. The same 
operators and analyzers (PC., D.S., A.D.) were involved in 
both London and Sydney over the duration of the study. We 
previously showed that this method is accurate and reproduc- 
ible for measurement of small changes in arterial diameter 
(16), with low interobserver error for measurement of flow- 
mediated dilation (13,17). The arterial diameter was measured 
zt a fixed distance from an anatomic marker (such as a fascial 
plane or vein seen in cross section) using ultrasound calipers. 
Measurements were taken from the anterior to the posterior 
“m line” at end-diastole. The mean diameter was calculated 
from four cardiac cycles incident with the R wave on the ECG. 
Brachial artery diameter measurements after reactive hyper- 
emia were taken 50 to 60 8 after cuff deflation. Diameter 
clmnges were derived as percent change re!ative to the first 
baseline scan (100%). Volume blood flow way calculated by 
multiplying the velocity time integral of the Doppler flow 
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Table 1. Brachial Artery Vascular Reactivity in Insulin-Dependent 
Diabetic and Control Subjects 
Control 
Subjects 
(n = 80) 
Diabetic 
Subjects 
(II = 80) p Value 
AIF W 29 rt 7 29 c 7 0.91 
Male 40 (50) 40 (SO) 1.0 
Systolic blood pressure (mm Hg) 112t 10 118 + 12 0.01 
Diastolic blood (mm Hg) pressure 7128 76 t IO 0.06 
Total cholesterol (mgkl) 174 + 4 197c4 - O.oill 
LDL cholesterol (m&il) 93 2 20 112-r-23 0.04 
HDL choleskrot (mgidl) 542 11 61 t 15 0.29 
Triglycerides (mgidi) 44” 18 46 + 96 < O.oi)l 
Lp(a) (mgldl) - 21+-23 
Vessel diameter (mm) 3.5 C 0.6 3.5 + 0.6 0.73 
Flow-mediated dilation (%) 9.3 i 3.8 5.0 f 3.7 <: 0.001 
GTN-induced dilation (%) 19.7 * 6.6 15.6 L 5.6 c 0.001 
Hyperemia (96) 495 2 183 479 5 174 0.60 
Baseline blood Row (mlimin) 60 5 34 55 -e 32 0.65 
Data presented are mean value it SD or number (%) of subjects. GTN = 
glyceryltrinitrate; HDL = high density lipoprotein; LDL = low density lipopro- 
tein; Lp(a) = lipoprotein(a); - = not measured in control subjects. 
signal (corrected for angle) by the heart rate and the vessel 
cross-sectional area (v X 3). The flow velocity used in our 
calculation is taken from the center of the artery and therefore 
gives an overestimate, but relative flow values before and after 
cuff inflation are accurate. Reactive hyperemia was calculated 
as the maximal flow measured during the first 15 s after cuff 
deflation divided by the flow during the first rest (baseline) 
scan. 
Statistics. Descriptive data are exprewch a~ qean value jL 
SD. The diabetic and control groups were compared using two 
sample (independent) t tests. For the whole group cf diabetic 
and control subjects, the relation between the dependent 
~riab:c (flow-mediated dilation: and presence or absence of 
diabetes, age, vessel size, LDL cholestrrol, triglycerides and 
fasting glucose) was explored using univariate and multivariate 
linear regression analyses. Similar analyses were performed for 
the diabetic subjects alone, including duration of diabetes, 
vessel diameter, systolic blood pressure, hemoglobin A,, LDL 
cholesterol and triglycerides as independent variables. These 
analyses were repeated using GIN-induced dilation as the 
dependent variable. Further univariate and multivariate anal- 
yses were Gsed to explore the relation of flow- and GTN- 
mediated dilation to fasting glucose, fastmg insulin, total daily 
insulin dose, HDL cholesterol, lipoprotein(a) and presence of 
microalbuminuriaitinopathy. In control subjects, univariate 
and multivariate analyses were performed to study the relation 
of Bow- and GTN-mediated dilation to age, vessel size, systolic 
blood pressure and cholesterol levels. Statistical significance 
was inferred at a p value ~0.05. 
Patient characteristics. The baseline characteristics of the 
control and diabetic subjects are provided ir; Table 1. Age and 
gender ratios were similar, but systolic blood pressure was 
slightly higher in the diabetic subjects. Total cholesterol, LDL 
cholesterol and triglyceride levels were significantly higher in 
the diabetic group (p < 0.05 for each comparison). Diabetes 
had been diagnosed since age 16 t 8 years (range 3 to 34) and 
had been present for 13 t: 8 years (range OS to 33) at the time 
of the study. Subjects were taking 46 L 16 units (range 22 to 
84) of insulin/day in a variety of preparations. Before vascular 
testing, fasting plasma glucose levels were 12.7 +- 6.2 mmol/ 
liter and fasting insulin leve!s 19.9 4 14.8 pmollliter in the 
diabetic subjects. Glycosylated hemoglobin levels indicated 
suboptimal control, as is common in this type of diabetic 
patient (mean hemoglobin A, 9.5 4 2.2%, range 5.8% to 
16.6%). No subject had clinical evidence of macrovascular 
disease (normal peripheral pulses and rest 12-lead EC<;). Nine 
diabetic subjects had evidence gf background and one of 
proliferative diabetic retinopatby, but none ?+nd clinically de- 
tectable peripheral neuropathy. Five diabetic subjects had 
microalbuminuria (defined as average urinary albumin excre- 
tion rate between 20 and 200 &min), but none had macro- 
proteinuria. Autonomic function tests were normal in ail 16 
subjects studied (this subgroup included those within a wide 
range of diabetes duration and control, representative of the 
group as a whole). 
Vascular studies. Vessel size, mean rest blood flow (ml/ 
min) and percent increase in blood Bow during reactive 
hyperemia did not differ between diabetic and control subjects 
(Table 1). Baseline characteristics and vascular responses were 
similar in diabetic patients recruited in both London and 
Sydney. In response to flow increase, the arteries of the control 
subjects dilated 9.3 rt 3.8% (range 0.6% to 21.6%). However, 
in the diabetic subjects, flow-mediated dilation was sign& 
cantiy impaired (5.0 -+ 3.7%, range -0.5% to 14.1%, p < 
OXKH). Glyceryltrinitrate-induced dilation was also attenuated 
in the diabetic subjects compared with that in control subjects 
(15.6 + 5.6%, range 3.4% to 30.7% in diabetic subjects; 19.7 + 
6.6<%, range 8.8% to 38.7% in control subjects, p < 0.001) (Fig. 
1). There was a positive correlation between flow-mediated 
and GTN-induced dilation (r = 0.31, p < OK!3 for the whole 
group). Similar correlations were found for both the diabetic 
subjects (r = 0.34) and the control subjects (y = C.57), although 
the s1ope.s of the regression lines were significantly different 
(p = 0.001). The ratio of flaw-mediated dilation to GTN- 
induced dilation was markedly lower in the diabetic subjects 
than in the control subjects (0.36 2 0.36 vs. 0.48 t 0.21, p = 
0.015), suggesting that the impaired dilator response to in- 
creased blood flow was out of proportion to th,: impaired 
dilator response to GTN. 
On univariate analysis, flow-mediated dilation in the dia- 
betic patients was inversely correlated with duration of diabe- 
tes (r = -0.24> p < &OS) and LDL cholesterol level (r = 
-0.42, p < 0.001) (Fig. 2) but not with age; systolic bloxf 
pressure; serum glucose concemration or insulin level; total 
daily insulin dose; glycosylated hemoglobin; triglyceride, WDL 
cholesterol and lipoprotein(a) leveis; or the presence of stm+ 
vessel disease (retinopathy or microalbuminuria, or both). ‘in 
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Figure 1. Flow-mediated dilation and glycetyltrinitrate (GTN)- 
induced dilation in diabetic and control subjects. 
the total study cohort (n = 160), the presence of diabetes and 
age, systolic blood pressure, LDL cholesterol, triglycerides, 
plasma glucose and vessel size were entered as independent 
variables against flow-mediated dilation in a multivariate re- 
gression analysis. The presence of diabetes was a major 
contributor to impaired flow-mediated dilation independent of 
plasma glucose concentration, systolic blood pressure and LDL 
cholesterol level (r = 0.41, p < 0.0001, multiple r value 0.66, F 
value 15.9). tLow density lipoprotein cholesterol levels and 
vessel size were also significantly correlated to flow-mediated 
dilation in this model (r = -0.24, p < 0.01 and r = -0.31, p < 
0.005, respectively). In a multivariate analysis of the diabetic 
subjects, flow-mediated dilation was correlated with both du- 
ration of diabetes (r = -0.26, p < 0.05) (Fig. 2a) and LDL 
cholesterol levels (r = -0.38, p < 0.005) (Fig. 2b) but not with 
vessel size, systolic blood pressure, glycosylated hemoglobin or 
@I 
15 r = 0.42 
p < o.oIM 
Figure 2. Relation between flow-mediated dilation, duration of dia- 
betes (a) and low density lipoprotein (LDL) cholesterol levels (b) in 
diabetic subjects. 
triglycerides (Table 2). In the control subjects, flow-mediated 
dilation was inversely correlated to vessel size but not to age, 
systolic blood pressure or cholesterol levels. 
A separate multivariate analysis was performed using the 
same independent variables against GTN-induced brachial 
artery dilator responses. In the diabetic subjects, GTN-induced 
Ci!ation was inversely correlated with duration of diabetes (r = 
-0.31, p < 0.05) and vessel size (r = -0.44, p < 0.005~ 
Table 2. Multiple Regression Ana!ysis for Determinants of 
Flow-Mediated Dilation in Diabettc Subjects* 
Variable 
Partial Regression P 
Coefficient value 
Duration of diabetes -0.26 0.05 
Vase1 diameter -0.10 0.45 
Systolic blood pressure -0.06 0.67 
Hemoglobin A, 0.10 0.47 
LDt. cholesterol -0.38 0.005 
Triglycerides -0.19 0.20 
*Multiple r value 0.54, F value 3.11. LDL = low density lipoprotein. 
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multiple r value 0.57, F value 3.03) but not w-ith cholesterol 
levels, markers of microvascular disease or control of diabetes. 
The present study shows that endothi’ia’ ‘unction is signif- 
icantly impaired in the large systemic arterres of asymptomatic 
young adults with insulin-dependent diabetes from as young as 
teenage years, in the absence of clinically detecctable athero- 
sclerotic disease. Impaired endothelial function was more 
common in subjects with a longer duration of diabetes and 
correlated strongly with J,DL cholesterol, even at ievels con- 
sidered acceptable in nondiabetic subjects. 
Endothelial function in diabetic patients. Previous studies 
in diabetic subjects have focused on vascular endothelial 
function in resistance vessels. De Tejada et al. (18) reported 
that endothelium-dependent dilation was impaired in the 
corpora cavernosum excised from impotent diabetic men. 
Calver et al. (19), using venous occlusion plethysmography, 
infused the specific antagonist to niiric oxide synthase (L- 
NMMA) and found the vasoconstrictor response diminished 
compared with that in normal subjects, suggesting impaired 
basal release of nitric oxide in diabetic subjects. Using a similar 
model, Johnstone et al. (20) found impaired endothclium- 
dependent dilation in insulin-dependent diabetic subjects in 
response to methacholine infusion. In one of the few studies of 
large-vessel vascular responses, Nitenberg et ai. (21 j demon- 
strated abnormal aeetylcholine-induced coronay; vasodilation 
in an invasive study of 11 mixed non-insulin-dependent and 
insulin-dependent diabetic patients with a mean age of 4S 
years. This evidence of disturbed endothelium-dependcrlt di- 
lation is supported by abnormalities of circulatory markers of 
endothelial damage such as von Willebrand factor (22 1. 
Our study examined vascular endothelial and smorxtb mus- 
cle function in the large vessels of young asymptomati? %~etic 
subjects. We used a simple noninvasivc test that enabled 
accurate and reproducible assessment of vascular responses in 
patients. The method involves comparison of vascular dilation 
with flow increase and GTN. Flow-mediated diiation is known 
to depend on the ability of healthy endothelium to release 
nitric oxide in response to shear stress. Our method induces 
reactive hyperemia by cuff occlusion and release dista] to the 
segment of artery under measurement. In this study, peak 
reactive hyperemia was not different in diabetic and control 
subjects, atthough an impairment of metabohc vasodilation 
cannot be excluded, because total Aow repayment after isch- 
emia could not be measured. Dilation in response to flow 
increase can be blocked by intraarterial infusion of I,-NJvJMA 
proximal to the measuring site but not by L-NMMA infusion 
distally, strongly suggesting that the response to JJow reflects 
endothelial function in large arteries (14). Further recent work 
(35) has indicated a close correlation between endothelial 
function in the brachial artery assessed using our method and 
endothe]iaJ function in the coronary artery assessed invasively 
using acetyicholine. We previously showed (16) using phan- 
tom studies, that high resolution ultrasound imaging can 
measure small changes in arterial diameter accurately and that 
these responses to flow are highJy reproducible in s&i 
measurements in patients. 
The mechanism by which diabetes contributes to endothe- 
lial dysfunction is unclear, but it is likely that JtypergJyyccmia is 
the initiating insult (23). There is evidence that both reduced 
synthesis and increased inactivation of nitric oxide are in- 
volved. Nitric oxide production may be reduced as a result of 
disruption to the nitric oxide signal transduction pathway at an 
early stage. In isolated arterial preparations in animals and 
humans, the pattern of vascular responses to bradykinin and 
acetylcholine in diabetic subjects (24) is similar to that seen in 
hypercholesterolemia (25) and established’atherosclerosis and 
suggests that the function of the Gr proiein may bc a critical 
factor in both. Elevated glucose levels may lead to a decrease 
in cellular nicotinamide adenine dinucleotide phosphate 
through activation of the polyol pethway (26) with consequent 
impairment of nitric oxide synthase activity, An abnorm .lity in 
the metabolism of arginine, the substrate for nitric oxide 
syntht%s, may also be important (27). Jncreased nitric oxide 
inacti /ation in diabetes may be mediated both by an increase in 
free radical production or by decreased free radical scavenger 
activi:y (28). There may also be an increased susceptibility to 
free radical-induced damage in the tissues of diabetic subjects 
(29). In our study there was no relation between endothelial 
dysfunction and Immediate pretest fasting plasma glucose or 
irrsuhii levels or markers of longer term glycemic control. The 
use of a single measure of glycosylated hemoglobin as a control 
marker has limitations, but our findings are in accord with 
clinical studies (30) that have shown that improved glycemic 
control alone is disappointing in preventing complications 
from large-vessel disease in insulin-dependent diabetes. In 
contrast, we found that the duration of diabetes is -elated to 
early large-vessel damage. This suggests that it is the length of 
the insult rather than the intensity of the hyperglycemia that. 
contributes to the degree of impzrired endothelial function. 
This parallels epidemiologic work that has shown that duration 
of diabetes correlates strongly both with small- and large-vessel 
disease (3J). Many factors that may be damaging to the 
endothelium in diabetes may be time dependent, including the 
generation of noncnzymic advanced g!ymsyl&~~ end prod- 
ucts (32). 
In the present study, GTN was an effective vasodilator in 
both control and diabetic subjects. The GTN response, how- 
ever, was impaired in the diabetic subjects, although not to the 
same degree as the impairment of endothelium-dependent 
Row responses. A similar trend has been noted in other groups 
affected by atherogenic risk factors, such as smoking or hyper- 
cholcsterolemia (17,33), and may be due to a diminished fhtw 
component of t;ie GTN response (31). A concomitant smooth 
mu&e problem, however, cannot be excluded, and our finding 
that diabetes duration and GTN response are inversely corre- 
lated is consistent with this hypothesis. The basis for the 
impairment of both endothelium-dependent dilation and the 
response !o GTN may be the accumulation of advanced 
glycosylation end products in the subendothelial space or. 
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alternatively, the increased free radical production or de- 
creased free radical scavenger activity (35). 
Cholesterol levels and endothelial function in diabetes. 
Our diabetic subjects had only mildly abnormal lipid profiles. 
Ti&r trig@cride levels showed no reiation with endothelial 
function, but there was a strong correlation between endothe- 
lial function and LDL cholesterol (r = -0.38). This is biolog- 
ically highly significant, especially when compared with the 
correlation between cholesterol and coronary disease seen in 
l&ye population studies such as the Framingham cohort (36). 
We previously demonstrated (33) impaired endothe!ial func- 
tion in children with familial hyperchoizsterolemia and in 
adults with elevated cholesterol levels (37). In the current 
study, there was no correlation between the LDL cholesterol 
levels and flow-mediated dilation in the nondiabetic control 
subjects, although this may reflect their relatively small range 
of cholesterol values. In the diabetic subjects, however, a 
strong correlation between impaired flow-mediated dilation 
and LDL cholesterol was found, despite the fact that LDL 
levels were only mildly elevated compared with those ;n the 
control subjects (mostly ~160 mgldl), supporting the concept 
that LDL cholesterol and diabetes may interact to increase the 
likelihood of early vascular damage. Th,:se findings have 
implications for the therapeutic targets for cholesterol lower- 
ing in diabetic subjects; it may be necessary to aim for a lower 
level of LDL cholesterol than is currently recommended for 
primary prevention in nondiabetic subjects. 
Study limitations. We purposely excluded patients >40 
years old, cigarette smokers and those with hypertension as a 
result of our previous studies (38), which showed an age- 
related decline in endothelium-dependent dilation from mid- 
dle age onward in both men and women, even in the absence 
of other risk factors. Cigarette smoking is also associated with 
profoundly disturbed -dscchu responses in young otherwise 
healthy subjects, ms&ng the effects of other risk factors such 
as cholesterol (17), The few hypertensive patients that we 
encountered in this young population were excluded because 
they were all taking vasoactive medication. As a result, we were 
unable to investigate the possibility suggested in epidemiologic 
studies that hypertension and smoking might interact synegis- 
tically with diabetes to impair endothelial function (as found 
for cholesterol in the present study) (3). There is a clear link 
between small-vessel disease as marked by the presence of 
microalbuminuria and cardiovascular morbidity and mortality 
(39). However, we were unable to examine the relation be- 
tween microalbuminuria and large-vessel endothelial function 
because an insufficient number of patients with early renal 
disease were studied. Qur data for young diabetic patients 
should not be extrapolated to the more common, non-insulin- 
dependent diabetic population because of the confounding 
influences of age, insulin resistance, dyslipidemia and hyper- 
tension on vascular damage in this older group. 
Clinical implications. Impaired endothelial function may 
result in the abnormal interaction between vessel wall, plate- 
lets and leukocytes as well as smooth muscle proliferation (5) 
and has lizen shown (7) to precede occlusive disease in both 
experimerltal p:imatc models and in clinical studies of early 
coronary disease, A follow-up period of nlany years would be 
required to show that young adult diabetic subjects wii h 
impaired endothelium-dependent dilation will go on to de- 
velop atherosclerosis and its complications. Nevertheless, our 
observations are likely to represent precliniczl vascular dam- 
age. Because the blood vessels of diabetic subjects seem 
partieularIy vulnerable to the adverse effects of elevated LDL 
cholesterol, prospective trials are required to evaluate active 
lipid-lowering strategies. A noninvasive test of arterial physi- 
010&y wili permit serial studies of Fuch interventions, as well as 
identibing subjects most at risk fbr developing arterial disease. 
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